ArticleInternational journal of chronic obstructive pulmonary disease2025
Global, Regional, and National Burden Trends in Chronic Obstructive Pulmonary Disease Attributable to Particulate Matter Pollution: 1990-2021 and Projections to 2036.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- The triple-hit hypothesis: exploring pulmonary e-cigarette, PMEuropean respiratory review : an official journal of the European Respiratory Society · 2026Review
- COPD in Africa in the Post-COVID Era: A GBD 2023 Analysis of Trends, Demographic Drivers and Health-System Performance.International journal of chronic obstructive pulmonary disease · 2026Article
- Construction and internal-external validation of a machine learning-based risk prediction model for multidrug resistance in ICU patients with acute exacerbation of chronic obstructive pulmonary disease.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, of which 41.27% of the burden may be related to particulate matter (PM) pollution. Understanding the PM-related burden of COPD at global, national and regional levels can provide evidence for public health policies. Methods: First, the numbers of death and disability-adjusted life year (DALY), and the corresponding age-standardized rates were assessed globally and by subtype, including age, sex, sociodemographic index (SDI), country, and region from 1990 to 2021. Second, the temporal trend in disease burden was estimated by joinpoint regression analysis. Furthermore, an international health inequality analysis was used to assess the inequality slope indices and concentration indices, and frontier analysis was performed to explore the current situation and potential improvement of disease burden control. Finally, we constructed an auto regressive integrated moving average model to predict PM-related burden of COPD in the next 15 years. Results: In 2021, the number of COPD deaths and DALYs attributed to PM were approximately 1.54 million and 33.24 million, respectively. The age-standardized death rate (ASMR) and age-standardized DALY rate (ASDR) were 1.66 and 1.50 times higher in males than in females. Interestingly, the ASMR and ASDR exhibited an increase from 2020 to 2021. The highest COPD burden attributed to PM was in low and low-middle SDI regions. Countries with an SDI between 0.3 and 0.6 had the greatest potential to reduce the COPD burden attributed to PM, especially in Asia, Oceania, and Africa. In the next 15 years, the ASMR and ASDR of COPD attributable to PM for both sexes will decrease, and the difference between male and female patients will be almost nonexistent. Conclusion: The COPD burden attributable to PM remains a long-term problem globally, especially in males, the older adults, and low and low-middle SDI regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.